Clinical relevance of CD44 cell surface expression and MYCN gene amplification in neuroblastoma

By Combaret V.   Gross N.   Lasset C.   Frappaz D.   Beretta-Brognara C.   Philip T.   Beck D.   Favrot M.C.  

European Journal of Cancer, Vol. 33, Iss. 12, 1997-10 ,pp. : 2101-2105

Elsevier

Access to resources Recommend Favorite

Analysis of candidate gene co-amplification with MYCN in neuroblastoma

By George R.E.   Kenyon R.   McGuckin A.G.   Kohl N.   Kogner P.   Christiansen H.   Pearson A.D.J.   Lunec J.  

European Journal of Cancer, Vol. 33, Iss. 12, 1997-10 ,pp. : 2037-2042

Elsevier

Access to resources Recommend Favorite

Microarray data analysis of neuroblastoma: Expression of SOX2 downregulates the expression of MYCN

By              

Molecular Medicine Reports, Vol. 12, Iss. 5, 2015-01 ,pp. : 6867-6872

Spandidos Publications

Access to resources Recommend Favorite

Changes in MYCN expression in human neuroblastoma cell lines following cisplatin treatment may not be related to MYCN copy numbers

By                

Oncology Reports, Vol. 29, Iss. 6, 2013-01 ,pp. : 2415-2421

Spandidos Publications

Access to resources Recommend Favorite

Neuroblastoma cells can actively eliminate supernumerary MYCN gene copies by micronucleus formation-sign of tumour cell revertance?

By Ambros I.M.   Rumpler S.   Luegmayr A.   Hattinger C.M.   Strehl S.   Kovar H.   Gadner H.   Ambros P.F.  

European Journal of Cancer, Vol. 33, Iss. 12, 1997-10 ,pp. : 2043-2049

Elsevier

Access to resources Recommend Favorite